E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/15/2005 in the Prospect News Convertibles Daily.

New Issue: Barclays sells $2.01 million 9% exchangeables linked to Merck

New York, March 15 - Barclays Bank plc priced $2.01 million of one-year 9% exchangeable notes linked to Merck & Co., Inc. common stock, according to a 424B2 filing with the Securities and Exchange Commission.

Issuer:Barclays Bank plc
Issue:Exchangeable senior medium-term notes
Underlying stock:Merck & Co., Inc.
Amount:$2.014 million
Maturity:March 16, 2006
Coupon:9%, payable monthly
Price:Par
Payout at maturity:Par in cash unless Merck stock closes lower than initial price of $32.16 and Merck stock closes below protection level at some point, in which case $1,000/$32.16 shares of Merck stock
Protection price:$27.34, 85% of initial price of $32.16
Exchange ratio:$1,000/$32.16
Exchange price:$32.16 (initial level of Merck stock)
Call:Non-callable
Pricing date:March 11
Settlement date:March 16
Lead manager:Barclays Capital
Distribution:Off shelf

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.